Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Osteoarthritis × Inosine Monophosphate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Osteoarthritis 1 Low Back Pain 1 Leukemia, Myeloid, Acute 1 Cancer Pain 1

Interventions

rofecoxib 1 World Health Organization oral rehydration solution 1 Vitamin D 1 Syringes 1 Nutrition Assessment 1 Inosine Monophosphate 1 Fish Oils 1 Fatty Acids, Omega-3 1 Eicosapentaenoic Acid 1 Duration of Therapy 1 Docosahexaenoic Acids 1 Cholecalciferol 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03031938 2021-06-25

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Pfizer

Phase 3 Completed

4 enrolled 78 charts

Cancer Pain, Osteoarthritis, Low Back Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡